Nucleic Acid Oligomer Deprotection with Low-Formaldehyde DCA

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for synthesizing nucleic acid oligomers using dichloroacetic acid solutions result in unsatisfactory yields, necessitating an improvement in the efficiency of nucleic acid oligomer production.

Innovation Solution

A method involving the use of a dichloroacetic acid solution with a formaldehyde concentration of 90×10−6 or less, along with specific reaction conditions and solvents, to enhance the yield of nucleic acid oligomers.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a conventional dichloroacetic acid solution is used for deprotection, then the synthesis process can proceed, but the yield of the nucleic acid oligomer is not satisfactory

Engineering Contradiction:
Improveyield of nucleic acid oligomerVSAvoidquality of dichloroacetic acid solution
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by specifying precise control of formaldehyde concentration (90×10⁻⁶ or less) and water content (5% or less) in the dichloroacetic acid solution. This quantitative parameter optimization directly resolves the contradiction by transforming the deprotection step into a high-yield process while maintaining solution quality standards.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements preliminary action by pre-purifying the dichloroacetic acid solution to remove formaldehyde and water contaminants before using it in the deprotection step. This advance preparation ensures that when the deprotection occurs, the reaction conditions are already optimized for high yield, eliminating the need for subsequent purification steps.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If a dichloroacetic acid solution with improved quality is used, then the yield improves, but the cost of reagent preparation increases

Engineering Contradiction:
Improveyield of nucleic acid oligomerVSAvoidsimplicity of reagent preparation
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent applies self-service by providing a standardized method for purifying dichloroacetic acid solution that can be performed in-house using simple equipment. The purification process uses basic laboratory apparatus (distillation setup, molecular sieves) and establishes clear operational parameters, enabling routine preparation without requiring specialized facilities or complex procedures.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent resolves the complexity issue by establishing specific parameter thresholds (formaldehyde ≤90×10⁻⁶, water ≤5%) that define when the reagent is sufficiently pure. These quantitative criteria provide clear decision points for when purification is needed and when commercial reagent is acceptable, simplifying the overall manufacturing process through objective parameter-based quality control.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method significantly improves the yield of nucleic acid oligomers, particularly ribonucleic acids, by optimizing the reaction conditions and solvent selection.

Implementation Method 1

the protecting group of the hydroxyl group at the 5′-position is deprotected using a dichloroacetic acid solution

Methodology Applied
Scientific EffectChemical deprotection:

Data Source

PatentUS12522629B2Method for producing nucleic acid oligomer
Publication Date: 2026.01.13 SUMITOMO CHEM CO LTD
  • US12522629B2 patent drawing
  • US12522629B2 patent drawing
  • US12522629B2 patent drawing

AI summary

The present invention provides a method for efficiently producing a nucleic acid oligomer. Specifically, the present invention provides a method for producing a nucleic acid oligomer represented by Formula (2), the method including a step of reacting a nucleic acid oligomer represented by Formula (1) with a dichloroacetic acid solution having a molar ratio of formaldehyde to dichloroacetic acid (formaldehyde mol/dichloroacetic acid mol) of 90×10−6 or less:wherein symbols have the meanings given in the description;wherein symbols have the meanings given in the description.